Frazier Lifesciences Acquisition - Warrants (09/12/2025) EBIT

Frazier Lifesciences Acquisition - Warrants (09/12/2025) (FLACW) currently reports a EBIT of $-5.1M as of September 2022. That compares with $-1M in the prior-year period — down 389.1% year over year. That is above the sector sector average of $-6.4M. Use the charts on this page to explore Frazier Lifesciences Acquisition - Warrants (09/12/2025)'s EBIT history and peer comparisons.

Frazier Lifesciences Acquisition - Warrants (09/12/2025)'s EBIT decreased from $-1M to $-5.1M — a 389.1% year-over-year decrease (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Frazier Lifesciences Acquisition - Warrants (09/12/2025)'s EBIT of $-5.1M is higher than the its sector sector average of $-6.4M. That is roughly 20.6% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Frazier Lifesciences Acquisition - Warrants (09/12/2025) reported $-5.1M in EBIT as of September 2022. That compares with $-1M in the prior-year period — down 389.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-5.1M, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $-6.4M. From there, open related valuation or income-statement pages for Frazier Lifesciences Acquisition - Warrants (09/12/2025), and consider following FLACW for alerts when major investors trade the stock.